Chronic Plantar Fasciitis
Conditions
Keywords
Chronic Plantar Fasciitis, Plantar Fascia Pain, Intense Therapeutic Ultrasound (ITU), Guided Therapy Systems (GTS), Ardent Sound, Inc., Actisound
Brief summary
Double-blinded feasibility study for the treatment of pain related to chronic plantar fasciitis. A total 37 patients (27 treated and 12 control/sham treated) received 2 treatments, 2 weeks apart on subcutaneous plantar fascia musculoskeletal tissue along with Standard of Care treatments as prescribed by the Principal Investigator. Patients were followed for up to 6 months after the first treatment receiving a physical exam at each follow-up visit (4, 8 and 12 weeks) and provided feedback via Patient/Subject Reported Outcome Measure surveys specific to the treated anatomy at each visit and via phone follow-up at 26 weeks after the first treatment.
Detailed description
Intense therapeutic ultrasound (ITU) is an established ultrasound based therapy in which sound waves are concentrated and focused into selected musculoskeletal tissue, to produce selective thermal coagulative changes over a small controlled area while leaving the surrounding tissue unaffected. These coagulative changes are known to begin the body's tissue response cascade and promote collagen generation in the targeted anatomy resulting in pain reduction. ITU has been used clinically for treating the subcutaneous musculoskeletal tissue below facial skin for the past decade and it has received CE Mark and FDA 510(k) clearance to market for non-surgical brow and submental tissue lifting. Over 3 Million patients worldwide have been treated using this technology. Clinical studies have shown that 85% of patients receiving this treatment on facial skin tissue showed an improvement in facial lifting with no significant pain, erythema, inflammation or scarring by creating the same coagulative changes to the connective tissue under the skin. Histologically, it has been shown that ITU induces the production of dermal collagen with thickening of the dermis and straightening of the elastic fibers in the reticular dermis. On-going research in laboratory studies has shown that ITU can improve healing of damaged Achilles tendon in a rabbit model. Preliminary results showed an increase in precursor markers for collagen regeneration (e.g. Vascular endothelial growth factor A (VEGFa), tumor necrosis factor alpha (TNFα), Interleukin 1 beta (IL-1β), and Transforming growth factor beta 1 (TGFβ1)) and subsequent increase in collagen formation in injured rabbit tendons treated with ITU compared to injured, untreated rabbit tendons.
Interventions
DEVICEIntense Therapeutic Ultrasound Treatment - ITU
Sponsors
University of Arizona
Guided Therapy Systems
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Masking description
Investigator was blinded to the treated vs. control/sham treated patient identity and to the treated foot. Researchers were blinded to the Investigators physical exam finding and patient outcome measure reports
Intervention model description
Adult Patients (age 18 - 85) of either gender diagnosed with chronic plantar fasciitis pain (\>90 days) where Standard of Care treatments had failed to reduce pain.
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* • Chronic Pain (\>90 days) from previously diagnosed Plantar Fasciitis, where Standard of Care regimens failed to relief pain in the affected anatomy. * No History of surgery to the affected anatomy. * No alternative treatment procedures within the last 90 days. * Unilateral Pain * Willingness to complete treatment and post treatment regimen as described. * Patients who have provided written and verbal informed consent
Exclusion criteria
* • Patients currently enrolled in any other non-conservative, device, or Investigational New Drug clinical trial, or who have participated in a clinical study involving the Plantar Fascia, thirty days prior to study initiation; * Patients who have participated in any other clinical study involving an investigational product 30 days prior to enrollment that, in the opinion of the Principal Investigator, could affect the outcome of this study; * Patients who have received previous treatment in the symptomatic limb (not including conservative treatment); * At the Principal Investigator's discretion, any patient that should be excluded based on their current condition or medical history.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average Percentage of Change as Reported Using Foot Function Index Pain Subscale | 12 weeks after 1st Treatment | Average Percentage of Change as Reported using Foot Function Index (FFI) pain subscale. Range (±100%). Foot Function Index pain subscale is a measure of pain and disability and activity limitation based 9 questions, each with a possible pain score of 0 - 10, where 0 indicates no pain during the described activity and 10 indicates the worst imaginable pain during a described activity. A summed total score of 0 indicates the patient had no pain for all activities. A score of 90 indicates the patient experiences the worst imaginable pain for all the described activities. The results compare the average percentage change of the FFI score at 12 weeks, compared to the average FFI score at baseline. |
| Mean Percentage Change in Volume of Plantar Fascia Hypoechoic Lesions by Diagnostic Ultrasound Imaging | 12 Weeks after the first Treatment | Mean Percentage Change in Volume of Plantar Fascia Hypoechoic Lesions by Diagnostic Ultrasound Imaging compared to Baseline Volume, where volume is calculated using: (4/3)π x R1 x R2 x R3, where R = Radius of each measurement: Lesion Length (1), Width (2), Depth (3). |
Countries
United States
Participant flow
Recruitment details
Patients 18 - 85 years previously diagnosed with unilateral Chronic Plantar Fasciitis (\>90 days), where Standard of Care therapies had failed to reduce pain.
Participants by arm
| Arm | Count |
|---|---|
| ITU Treatment for Chronic Plantar Fasciitis Intense Therapeutic Ultrasound (ITU) treatment applied along the length and width of the Plantar Fascia: 350 - 5 Joule pulses were applied twice, two weeks apart.
Intense Therapeutic Ultrasound Treatment - ITU | 29 |
| Sham ITU Treatment for Chronic Plantar Fasciitis Sham / Placebo Intense Therapeutic Ultrasound treatment (ITU) applied along the length and width of the Plantar Fascia: 350 - 0 Joule pulses were applied twice, two weeks apart.
Intense Therapeutic Ultrasound Treatment - ITU | 12 |
| Total | 41 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 7 | 4 |
Baseline characteristics
| Characteristic | Sham ITU Treatment for Chronic Plantar Fasciitis | Total | ITU Treatment for Chronic Plantar Fasciitis |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 1 Participants | 2 Participants | 1 Participants |
| Age, Categorical Between 18 and 65 years | 11 Participants | 39 Participants | 28 Participants |
| Age, Continuous | 47 years | 51 years | 54 years |
| Race and Ethnicity Not Collected | — | 0 Participants | — |
| Region of Enrollment United States | 12 participants | 41 participants | 29 participants |
| Sex: Female, Male Female | 8 Participants | 32 Participants | 24 Participants |
| Sex: Female, Male Male | 4 Participants | 9 Participants | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 29 | 0 / 12 |
| serious Total, serious adverse events | 0 / 29 | 0 / 12 |
Outcome results
Primary
Average Percentage of Change as Reported Using Foot Function Index Pain Subscale
Average Percentage of Change as Reported using Foot Function Index (FFI) pain subscale. Range (±100%). Foot Function Index pain subscale is a measure of pain and disability and activity limitation based 9 questions, each with a possible pain score of 0 - 10, where 0 indicates no pain during the described activity and 10 indicates the worst imaginable pain during a described activity. A summed total score of 0 indicates the patient had no pain for all activities. A score of 90 indicates the patient experiences the worst imaginable pain for all the described activities. The results compare the average percentage change of the FFI score at 12 weeks, compared to the average FFI score at baseline.
Time frame: 12 weeks after 1st Treatment
Population: Total population of respondents at 12 weeks.
| Arm | Measure | Value (MEAN) |
|---|---|---|
| ITU Treatment for Chronic Plantar Fasciitis | Average Percentage of Change as Reported Using Foot Function Index Pain Subscale | -54 percentage of Change |
| Sham ITU Treatment for Chronic Plantar Fasciitis | Average Percentage of Change as Reported Using Foot Function Index Pain Subscale | -25 percentage of Change |
Primary
Mean Percentage Change in Volume of Plantar Fascia Hypoechoic Lesions by Diagnostic Ultrasound Imaging
Mean Percentage Change in Volume of Plantar Fascia Hypoechoic Lesions by Diagnostic Ultrasound Imaging compared to Baseline Volume, where volume is calculated using: (4/3)π x R1 x R2 x R3, where R = Radius of each measurement: Lesion Length (1), Width (2), Depth (3).
Time frame: 12 Weeks after the first Treatment
Population: Male and Female previously diagnosed with Chronic Plantar Fasciitis, between the age of 18 and 85.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| ITU Treatment for Chronic Plantar Fasciitis | Mean Percentage Change in Volume of Plantar Fascia Hypoechoic Lesions by Diagnostic Ultrasound Imaging | -81 percentage of Hypoechoic Lesion Change | Standard Error 8 |
| Sham ITU Treatment for Chronic Plantar Fasciitis | Mean Percentage Change in Volume of Plantar Fascia Hypoechoic Lesions by Diagnostic Ultrasound Imaging | 26 percentage of Hypoechoic Lesion Change | Standard Error 4 |